Literature DB >> 12513857

Morphology of spermatozoa used in IVF and ICSI from oligozoospermic men.

Erik Høst1, Erik Ernst, Svend Lindenberg, Steen Smidt-Jensen.   

Abstract

The purpose of this study was to determine morphology in human spermatozoa from men with oligozoospermia and correlate with the fertilization rate, embryo score and pregnancy rate after IVF and intracytoplasmic sperm injection (ICSI) respectively. The study group consisted of 125 couples where the male partner suffered from oligozoospermia. Fifty of these had IVF (group A). Seventy-five couples in whom ICSI had been performed made up group B. Sperm samples were assessed according to the WHO manual. For each male, morphology of spermatozoa was judged according to Krüger's strict criteria, WHO criteria and the teratozoospermia index (TZI). Oocyte monitoring was carried out according to a long down-regulation protocol using gonadotrophin-releasing hormone, recombinant FSH and human chorionic gonadotrophin. Embryos were transferred on day 2 after fertilization, with a maximum of three embryos. This study demonstrated no correlation between any of the morphological assessments of spermatozoa and the fertilization rate, embryo score and pregnancy rate, either after IVF or ICSI. Morphology in human spermatozoa according to Krüger's strict criteria, WHO criteria and the TZI had no predictive value for the outcome after either IVF or ICSI.

Entities:  

Year:  2001        PMID: 12513857     DOI: 10.1016/s1472-6483(10)62038-x

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  2 in total

1.  Male age influences oocyte-donor program results.

Authors:  Eliezer Girsh; Nathan Katz; Leonid Genkin; Ofer Girtler; Jaron Bocker; Sofa Bezdin; Ilya Barr
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

2.  Male Infertility and Sperm DNA Fragmentation.

Authors:  Afrim Zeqiraj; Sheqibe Beadini; Nexhbedin Beadini; Hesat Aliu; Zafer Gashi; Shkelzen Elezaj; Sadi Bexheti; Agim Shabani
Journal:  Open Access Maced J Med Sci       Date:  2018-08-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.